Mail

UK markets closed

FTSE 100
8,139.83
+60.97(+0.75%)
FTSE 250
19,824.16
+222.18(+1.13%)
AIM
755.28
+2.16(+0.29%)
GBP/EUR
1.1679
+0.0022(+0.19%)
GBP/USD
1.2491
-0.0020(-0.16%)
Bitcoin GBP
51,136.56
-917.82(-1.76%)

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

Addex Therapeutics Ltd (ADXN)

NasdaqCM - NasdaqCM Real-time price. Currency in USD

Add to watchlist

16.10

+0.69

(+4.48%)

At close: 04:00PM EDT

Currency in USD

Valuation measures⁴

Market cap (intra-day)	16.13M
Enterprise value	12.28M
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	5.39
Price/book (mrq)	13.11
Enterprise value/revenue	7.61
Enterprise value/EBITDA	-1.20

Trading information

Stock price history

Beta (5Y monthly)	1.76
52-week change ³	8.52%
S&P500 52-week change ³	21.08%
52-week high ³	27.90
52-week low ³	5.00
50-day moving average ³	14.41
200-day moving average ³	9.73

Share statistics

Avg vol (3-month) ³	16.68k
Avg vol (10-day) ³	13.73k
Shares outstanding ⁵	1.07M
Implied shares outstanding ⁶	1.16M
Float ⁸	71.47M
% held by insiders ¹	0.00%
% held by institutions ¹	18.33%
Shares short (15 Apr 2024) ⁴	21.71k
Short ratio (15 Apr 2024) ⁴	1.18
Short % of float (15 Apr 2024) ⁴	N/A
Short % of shares outstanding (15 Apr 2024) ⁴	2.03%
Shares short (prior month 15 Mar 2024) ⁴	11.89k

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	1:20
Last split date ³	23 Oct 2023

Financial highlights

Currency in CHF.

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	0.00%
Operating margin (ttm)	-1,459.20%

Management effectiveness

Return on assets (ttm)	-99.44%
Return on equity (ttm)	-348.48%

Income statement

Revenue (ttm)	1.65M
Revenue per share (ttm)	2.64
Quarterly revenue growth (yoy)	-69.30%
Gross profit (ttm)	N/A
EBITDA	-10.26M
Net income avi to common (ttm)	-10.56M
Diluted EPS (ttm)	-18.43
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	3.87M
Total cash per share (mrq)	0.03
Total debt (mrq)	344.34k
Total debt/equity (mrq)	30.06%
Current ratio (mrq)	1.46
Book value per share (mrq)	0.01

Cash flow statement

Operating cash flow (ttm)	-7.99M
Levered free cash flow (ttm)	-4.22M